Literature DB >> 29405307

Feasibility of real-time motion management with helical tomotherapy.

Eric Schnarr1, Matt Beneke1, Dylan Casey1, Edward Chao1, Jonathan Chappelow1, Andrea Cox1, Doug Henderson1, Petr Jordan1, Etienne Lessard1, Dan Lucas1, Andriy Myronenko1, Calvin Maurer1.   

Abstract

PURPOSE: This study investigates the potential application of image-based motion tracking and real-time motion correction to a helical tomotherapy system.
METHODS: A kV x-ray imaging system was added to a helical tomotherapy system, mounted 90 degrees offset from the MV treatment beam, and an optical camera system was mounted above the foot of the couch. This experimental system tracks target motion by acquiring an x-ray image every few seconds during gantry rotation. For respiratory (periodic) motion, software correlates internal target positions visible in the x-ray images with marker positions detected continuously by the camera, and generates an internal-external correlation model to continuously determine the target position in three-dimensions (3D). Motion correction is performed by continuously updating jaw positions and MLC leaf patterns to reshape (effectively re-pointing) the treatment beam to follow the 3D target motion. For motion due to processes other than respiration (e.g., digestion), no correlation model is used - instead, target tracking is achieved with the periodically acquired x-ray images, without correlating with a continuous camera signal.
RESULTS: The system's ability to correct for respiratory motion was demonstrated using a helical treatment plan delivered to a small (10 mm diameter) target. The phantom was moved following a breathing trace with an amplitude of 15 mm. Film measurements of delivered dose without motion, with motion, and with motion correction were acquired. Without motion correction, dose differences within the target of up to 30% were observed. With motion correction enabled, dose differences in the moving target were less than 2%. Nonrespiratory system performance was demonstrated using a helical treatment plan for a 55 mm diameter target following a prostate motion trace with up to 14 mm of motion. Without motion correction, dose differences up to 16% and shifts of greater than 5 mm were observed. Motion correction reduced these to less than a 6% dose difference and shifts of less than 2 mm.
CONCLUSIONS: Real-time motion tracking and correction is technically feasible on a helical tomotherapy system. In one experiment, dose differences due to respiratory motion were greatly reduced. Dose differences due to nonrespiratory motion were also reduced, although not as much as in the respiratory case due to less frequent tracking updates. In both cases, beam-on time was not increased by motion correction, since the system tracks and corrects for motion simultaneously with treatment delivery.
© 2018 The Authors. Medical Physics published by Wiley periodicals, Inc. on behalf of American Association of Physicists in Medicine.

Entities:  

Keywords:  gating; internal-external correlation; intrafraction motion; organ motion; tomotherapy

Mesh:

Year:  2018        PMID: 29405307     DOI: 10.1002/mp.12791

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  14 in total

1.  The markerless lung target tracking AAPM Grand Challenge (MATCH) results.

Authors:  Marco Mueller; Per Poulsen; Rune Hansen; Wilko Verbakel; Ross Berbeco; Dianne Ferguson; Shinichiro Mori; Lei Ren; John C Roeske; Lei Wang; Pengpeng Zhang; Paul Keall
Journal:  Med Phys       Date:  2021-12-29       Impact factor: 4.071

2.  Evaluation of the target dose coverage of stereotactic body radiotherapy for lung cancer using helical tomotherapy: A dynamic phantom study.

Authors:  Masahide Saito; Hidekazu Suzuki; Naoki Sano; Kazunari Ashizawa; Kazuya Yoshizawa; Yuki Shibata; Koji Ueda; Takafumi Komiyama; Kan Marino; Shinichi Aoki; Ryo Saito; Yoshiyasu Maehata; Hiroshi Onishi
Journal:  Rep Pract Oncol Radiother       Date:  2020-01-14

3.  Effects of variable-width jaw motion on beam characteristics for Radixact Synchrony®.

Authors:  William S Ferris; Wesley S Culberson; Jennifer B Smilowitz; John E Bayouth
Journal:  J Appl Clin Med Phys       Date:  2021-03-29       Impact factor: 2.102

4.  Using 4D dose accumulation to calculate organ-at-risk dose deviations from motion-synchronized liver and lung tomotherapy treatments.

Authors:  William S Ferris; Edward H Chao; Jennifer B Smilowitz; Randall J Kimple; John E Bayouth; Wesley S Culberson
Journal:  J Appl Clin Med Phys       Date:  2022-04-29       Impact factor: 2.243

5.  Technical Note: Comprehensive performance tests of the first clinical real-time motion tracking and compensation system using MLC and jaws.

Authors:  Guang-Pei Chen; An Tai; Timothy D Keiper; Sara Lim; X Allen Li
Journal:  Med Phys       Date:  2020-05-11       Impact factor: 4.071

6.  Technical Note: Patient dose from kilovoltage radiographs during motion-synchronized treatments on Radixact®.

Authors:  William S Ferris; Wesley S Culberson
Journal:  Med Phys       Date:  2020-10-14       Impact factor: 4.071

7.  Dose delivery accuracy on helical tomotherapy for 4-dimensional tumor motion - a phantom study.

Authors:  Raghavendra Holla; David Khanna; V K Sathiya Narayanan
Journal:  Rep Pract Oncol Radiother       Date:  2021-06-09

8.  Evaluation of radixact motion synchrony for 3D respiratory motion: Modeling accuracy and dosimetric fidelity.

Authors:  William S Ferris; Michael W Kissick; John E Bayouth; Wesley S Culberson; Jennifer B Smilowitz
Journal:  J Appl Clin Med Phys       Date:  2020-07-21       Impact factor: 2.102

9.  Helical tomotherapy: Comparison of Hi-ART and Radixact clinical patient treatments at the Technical University of Munich.

Authors:  K M Kraus; S Kampfer; J J Wilkens; L Schüttrumpf; S E Combs
Journal:  Sci Rep       Date:  2020-03-18       Impact factor: 4.379

Review 10.  Image guidance in radiation therapy for better cure of cancer.

Authors:  Vincent Grégoire; Matthias Guckenberger; Karin Haustermans; Jan J W Lagendijk; Cynthia Ménard; Richard Pötter; Ben J Slotman; Kari Tanderup; Daniela Thorwarth; Marcel van Herk; Daniel Zips
Journal:  Mol Oncol       Date:  2020-06-29       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.